يعرض 1 - 20 نتائج من 677 نتيجة بحث عن '"megacólon"', وقت الاستعلام: 0.51s تنقيح النتائج
  1. 1
    Academic Journal
  2. 2
    Academic Journal
  3. 3
    Book
  4. 4
    Academic Journal
  5. 5
    Academic Journal
  6. 6
  7. 7
    Academic Journal
  8. 8
  9. 9
    Academic Journal
  10. 10
    Academic Journal
  11. 11
    Academic Journal
  12. 12
    Academic Journal
  13. 13
    Academic Journal
  14. 14
    Academic Journal
  15. 15
  16. 16
    Academic Journal
  17. 17
    Academic Journal
  18. 18
    Academic Journal
  19. 19
  20. 20
    Academic Journal

    المصدر: Acta Biomedica Scientifica; Том 8, № 4 (2023); 234-247 ; 2587-9596 ; 2541-9420

    وصف الملف: application/pdf

    Relation: https://www.actabiomedica.ru/jour/article/view/4362/2620; Skally M, Bennett K, Burns K, Brennan R, Finn C, O’Connell K, et al. A decade of Clostridioides difficile infection: A constant challenge to maintain the status quo. J Hosp Infect. 2023; 135: 59-66. doi:10.1016/j.jhin.2023.02.008; Sadeghifard N, Salari MH, Ghassemi MR, Eshraghi S, Amin Harati F. The incidence of nosocomial toxigenic Clostridium difficile associated diarrhea in Tehran tertiary medical centers. Acta Medica Iranica. 2010; 48(5): 320-325.; Белоус С.С., Сухина М.А., Халиф И.Л., Кашников В.Н., Веселов А.В., Шелыгин Ю.А. Первый опыт успешного лечения псевдомембранозного колита аутоштаммами лактобацилл. Экспериментальная и клиническая гастроэнтерология. 2018; 160(12): 47-50. doi:10.31146/1682-8658-ecg-160-12-47-50; Захаренко С.М. Clostridioides difficile: название новое, проблемы диагностики и терапии прежние. Альманах клинической медицины. 2022; 50(6): 377-391. doi:10.18786/2072-0505- 2022-50-048; Lim SC, Knight DR, Riley TV. Clostridium difficile and one health. Clin Microbiol Infect. 2020; 26(7): 857-863. doi:10.1016/j.cmi.2019.10.023; Khanna S, Pardi DS, Aronson SL, Kammer PP, Orenstein R, St Sauver JL, et al. Theepidemiology of community-acquired Clostridium difficile infection: A population-based study. Am J Gastroenterol. 2011; 107(1): 89-95. doi:10.1038/ajg.2011.398; Neemann K, Freifeld A. Clostridium difficile-associated diarrhea in the oncology patient. J Oncol Practice. 2017; 13(1): 25-30. doi:10.1200/JOP.2016.018614; Ramesh AS, Munoz Tello C, Jamil D, Tran HH, Mansoor M, Butt SR et al. Role of fecal microbiota transplantation in reducing Clostridioides difficile infection-associated morbidity and mortality: A systematic review. Cureus. 2022; 14(8): e28402. doi:10.7759/cureus.28402; Harries RL, Ansell J, Codd RJ, Williams GL. A systematic review of Clostridium difficile infection following reversal of ileostomy. Colorectal Dis. 2017; 19(10): 881-887. doi:10.1111/codi.13873; Bartlett JG. Historical perspectives on studies of Clostridium difficile and C. difficile infection. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2008; 46(Suppl 1): S4-S11. doi:10.1086/521865; Heinlen L, Ballard JD. Clostridium difficile infection. Am J Med Sci. 2010; 340(3): 247-252. doi:10.1097/MAJ.0b013e3181e939d8; Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis. 1977; 136: 701-705. doi:10.1093/infdis/136.5.701; Bartlett JG, Moon N, Chang TW, Taylor N, Onderdonk AB. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology. 1978; 75: 778-782.; Kuipers EJ, Surawicz CM. Clostridium difficile infection. Lancet. 2008; 371(9623): 1486-1488. doi:10.1016/S0140-6736(08)60635-2; Czepiel J, Dróżdż M, Pituch H, Kuijper EJ, Perucki W, Mielimonka A, et al. Clostridium difficile infection. Eur J Clin Microbiol Infect Dis. 2019; 38(7): 1211-1221. doi:10.1007/s10096-019-03539-6; Crobach MJ, Dekkers OM, Wilcox MH, Kuijper EJ. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): Data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect. 2009; 15(12): 1053-1066. doi:10.1111/j.1469-0691.2009.03098.x; Buonomo EL, Petri WA. The microbiota and immune response during Clostridium difficile infection. Anaerobe. 2016; (41): 79-84. doi:10.1016/j.anaerobe.2016.05.009; von Eichel-Streiber C, Warfolomeow I, Knautz D, Sauerborn M, Hadding U. Morphological changes in adherent cells induced by Clostridium difficile toxins. Biochem Soc Transact. 1991; 19(4): 1154-1160. doi:10.1042/bst0191154; Thibault A, Miller MA, Gaese C. Risk factors for the development of Clostridium difficile-associated diarrhea during a hospital outbreak. Infect Control Hosp Epidemiol. 1991; 12(6): 345-348. doi:10.1086/646354; Kim J, Pai H, Seo MR, Kang JO. Epidemiology and clinical characteristics of Clostridium difficile infection in a Korean Tertiary Hospital. J Kor Med Sci. 2011; 10(26): 1258-1264. doi:10.3346/jkms.2011.26.10.1258; McEllistrem MC, Carman RJ, Gerding DN, Genheimer CW, Zheng L. A hospital outbreak of Clostridium difficile disease associated with isolates carrying binary toxin genes. Clin Infect Dis. 2005; 40: 265-272. doi:10.1086/427113; Lyerly DM, Barroso LA, Wilkins TD. Identification of the latex test-reactive protein of Clostridium difficile as glutamate dehydrogenase. J Clin Microbiol. 1991; 29: 2639-2642. doi:10.1128/jcm.29.11.2639-2642.1991; Shim JK, Johnson S, Samore MH, Bliss DZ, Gerding DN. Primary symptomless colonisation by Clostridium difficile and decreased risk of subsequent diarrhoea. Lancet. 1998; 351: 633-636. doi:10.1016/S0140-6736(97)08062-8; Warny M, Vaerman JP, Avesani V, Delmee M. Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection. Infect Immun. 1994; 62: 384-389. doi:10.1128/iai.62.2.384-389.1994; Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013; 108(4): 478-498; quiz 499. doi:10.1038/ajg.2013.4; Prendergast TM, Marini CP, D’Angelo AJ. Surgical patients with pseudomembranous colitis: Factors affecting prognosis. Surgery. 1994; 116: 768-774; discussion 774-775.; Rubin MS, Bodenstein LE, Kent KC. Severe Clostridium difficile colitis. Dis Colon Rectum. 1995; 38: 350-354. doi:10.1007/BF02054220; Brown CH, Ferrante WA, Davis WD. Toxic dilatation of the colon complicating pseudomembranous enterocolitis. Am J Digest Dis. 1968; 13(9): 813-821. doi:10.1007/BF02233098; Trudel JL, Deschenes M, Mayrand S, Barkun AN. Toxic megacolon complicating pseudomembranous enterocolitis. Dis Colon Rectum. 1995; 38: 1033-1038. doi:10.1007/BF02133974; Finn E, Andersson FL, Madin-Warburton M. Burden of Clostridioides difficile infection (CDI) – A systematic review of the epidemiology of primary and recurrent CDI. BMC Infect Dis. 2021; 21(1): 456. doi:10.1186/s12879-021-06147-y; Kyne L, Warny M, Qamar A, Kelly CP. Association betweenantibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet. 2001; 357: 189-193. doi:10.1016/S0140-6736(00)03592-3; Pepin J, Alary ME, Valiquette L, Raiche E, Ruel J, Fulop K, et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis. 2005; 40: 1591-1597. doi:10.1086/430315; Chung MS, Kim J, Kang JO, Pai H. Impact of malignancy on Clostridium difficile infection. Eur J Clin Microbiol Infect Dis. 2016; 35(11): 1771-1776. doi:10.1007/s10096-016-2725-6; Shen B, Lin S, Shueng P, Chou Y, Tseng L, Hsieh C. Pseudomembranous colitis with in radiotherapy field following concurrent chemoradiation therapy: A case report. Onco Targets Ther. 2013; 6: 25-28. doi:10.2147/OTT.S40145; Peterz A, Shlomo BI, Nitzan O, Bonavina L, Schaffer MP, Schaffer M. Clostridium difficile infection: Association with chemotherapy, radiation therapy and targeting therapy treatments. Curr Med Chem. 2016; 23(39). doi:10.2174/0929867323666161028162018; Delgado A, Reveles IA, Cabello FT, Reveles KR. Poorer outcomes among cancer patients diagnosed with Clostridium difficile infections in United States community hospitals. BMC Infect Dis. 2017; 17(1): 448. doi:10.1186/s12879-017-2553-z; Kawamoto S, Horton KM, Fishman EK. Pseudomembranouscolitis: Can CT predict which patients will need surgical intervention? J Comput Assist Tomogr. 1999; 23: 79-85. doi:10.1097/00004728-199901000-00017; Morales Chamorro RM, Serrano Blanch R, Méndez Vidal MJ, Gómez España MA, Rubio Pérez MJ, de la Haba Rodríguez J, et al. Pseudomembranous colitis associated with chemotherapy with 5-fluorouracil. Clin Transl Oncol. 2005; 7(6): 258-261. doi:10.1007/BF02710173; Olson MM, Shanholtzer CJ, Lee JT Jr, Gerding DN. Ten years of prospective Clostridium difficile-associated disease surveillance and treatment at the Minneapolis VA Medical Center, 1982–1991. Infect Control Hosp Epidemiol. 1994; 15: 371-381. doi:10.1086/646934; Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol. 2010; 31(5): 431-455. doi:10.1086/651706; Parmar SR, Bhatt V, Yang J, Zhang Q, Schuster M. A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies. J Oncol Pharm Pract. 2013; 20(3): 172-182. doi:10.1177/1078155213490004; Tsuchida K, Hayashi T, Hayashi S, Sawazaki S, Jin Y, Hasuo K, et al. A case of pseudomembranous colitis with febrile neutropenia induced by chemotherapy and effectively treated by vancomycin enemas. Gan To Kagaku Ryoho. Cancer & Chemotherapy. 2010; 37(9): 1821-1823.; Bolton RP, Culshaw MA. Faecal metronidazole concentrationsduring oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile. Gut. 1986; 27: 1169-1172. doi:10.1136/gut.27.10.1169; Apisarnthanarak A, Razavi B, Mundy LM. Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: Case series and review of the literature. Clin Infect Dis. 2002; 35: 690. doi:10.1086/342334; Rubin DT, Sohi S, Glathar M, Thomas T, Yadron N, Surma BL. Rifaximin is effective for the treatment of Clostridium difficile-associated diarrhea: Results of an open-label pilot study. Gastroenterol Res Pract. 2011; 2011: 106978. doi:10.1155/2011/106978; Khoruts A, Staley C, Sadowsky MJ. Faecal microbiota transplantation for Clostridioides difficile: Mechanisms and pharmacology. Nat Rev Gastroenterol Hepatol. 2021; 18(1): 67-80. doi:10.1038/s41575-020-0350-4; Mittal C, Miller N, Meighani A, Hart BR, John A, Ramesh M. Fecal microbiota transplant for recurrent Clostridium difficile infection after peripheral autologous stem cell transplant for diffuse large B-cell lymphoma. Bone Marrow Transplantation. 2015; 50(7): 1010-1010. doi:10.1038/bmt.2015.85; Neemann K, Eichele DD, Smith PW, Bociek R, Akhtari M, Freifeld A. Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patient. Transpl Infect Dis. 2012; 14(6): E161-E165. doi:10.1111/tid.12017; Karlowsky JA, Laing NM, Zhanel GG. In vitro activity of OPT80 tested against clinical isolates of toxin-producing Clostridium difficile. Antimicrob Agents Chemother. 2008; 52(11): 4163-4165. doi:10.1128/AAC.00476-08; Buddle JE, Fagan RP. Pathogenicity and virulence of Clostridioides difficile. Virulence. 2023; 14(1): 2150452. doi:10.1080/21505594.2022.2150452; Johnson S, Lavergne V, Skinner AM, Gonzales-Luna AJ, Garey KW, Kelly CP, et al. Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults. Clin Infect Dis. 2021; 73(5): 755-757. doi:10.1093/cid/ciab718; Lipsett PA, Samantaray DK, Tam ML. Pseudomembranous colitis: A surgical disease? Surgery. 1994; 116: 491-496.; Koss K, Clark MA, Sanders DS. The outcome of surgery in fulminant Clostridium difficile colitis. Colorectal Dis. 2006; 8: 149-154. doi:10.1111/j.1463-1318.2005.00876.x; Longo WE, Mazuski JE, Virgo KS. Outcome after colectomy for Clostridium difficile colitis. Dis Colon Rectum. 2004; 47: 1620-1626. doi:10.1007/s10350-004-0672-2; Klipfel AA, Schein M, Fahoum B. Acute abdomen and Clostridium difficile colitis: Still a lethal combination. Dig Surg. 2000; 17: 160-163. doi:10.1159/000018821; Sailhamer EA, Carson K, Chang Y, Zacharias N, Spaniolas K, Tabbara M, et al. Fulminant Clostridium difficile colitis: Patterns of care and predictors of mortality. Arch Surg. 2009; 144: 433-439; discussion 439-440.; Kelly CR, Fischer M, Allegretti JR, LaPlante K, Stewart DB, Limketkai BN, et al. ACG clinical guidelines: Prevention, diagnosis, and treatment of Clostridioides difficile infections. Am J Gastroenterol. 2021; 116(6): 1124-1147. doi:10.14309/ajg.0000000000001278; Ahmed N, Kuo YH. Outcomes of total versus partial colectomy in fulminant Clostridium difficile colitis: A propensity matched analysis. World J Emerg Surg. 2022; 17(1): 11. doi:10.1186/s13017-022-00414-2; Peprah D, Chiu AS, Jean RA, Pei KY. Comparison of outcomes between total abdominal and partial colectomy for the management of severe, complicated Clostridium difficile infection. J Am Coll Surg. 2019; 228(6): 925-930. doi:10.1016/j.jamcollsurg.2018.11.015; Sartelli M, Di Bella S, McFarland LV, Khanna S, FuruyaKanamori L, Abuzeid N, et al. 2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients. World J Emerg Surg. 2019; 14: 8. doi:10.1186/s13017-019-0228-3; Pepin J, Vo TT, Boutros M, Marcotte E, Dial S, Dubé S, et al. Risk factors for mortality following emergency colectomy for fulminant Clostridium difficile infection. Dis Colon Rectum. 2009; 52: 400-405. doi:10.1007/DCR.0b013e31819a69aa; Шелыгин Ю.А., Алёшкин В.А., Сухина М.А., Миронов А.Ю., Брико Н.И., Козлов Р.С., и др. Клинические рекомендации Национальной ассоциации специалистов по контролю инфекций, связанных с оказанием медицинской помощи, и общероссийской общественной некоммерческой организации «Ассоциация колопроктологов России» по диагностике, лечению и профилактике Clostridium difficile-ассоциированной диареи (CDI). Колопроктология. 2018; (3): 7-23. doi:10.33878/2073-7556-2018-0-3-7-23; Zafar AB, Gaydos LA, Furlong WB, Nguyen MH, Mennonna PA. Effectiveness of infection control program in controlling nosocomial Clostridium difficile. Am J Infect Control. 1998; 26: 588-93. doi:10.1053/ic.1998.v26.a84773; https://www.actabiomedica.ru/jour/article/view/4362